Laura Strong

@scientre

Sci(entist)Entre(preneur) Work to detect cancer earlier. Prior cancer drug development & innovation. Teach UWMadison

TBD
Vrijeme pridruživanja: lipanj 2010.

Tweetovi

Blokirali ste korisnika/cu @scientre

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @scientre

  1. 29. sij

    Thanks for the excuse to celebrate Winnie and her success in building the incredible, mission-driven

    Poništi
  2. 15. sij
    Poništi
  3. 29. pro 2019.

    I had the good fortune to work with Amy on Doyenne. Her energy and support of women taking their businesses to the next level was inspiring.

    Poništi
  4. proslijedio/la je Tweet
    9. pro 2019.

    Hey , do you know how to access investigational agents to treat refractory for pts who can’t join ? ’s Project Facilitate staff can help w/ requests. Real humans in real time M-F 8a-4:30p.

    , , i još njih 7
    Poništi
  5. 15. stu 2019.
    Poništi
  6. proslijedio/la je Tweet
    13. stu 2019.

    They had me with “we recruited 420k subjects in 8 months”! Whole new era starting.

    Poništi
  7. 10. stu 2019.

    Abstract 109 "Combined Methylated DNA and Protein Markers: An Accurate Blood‐Based Test for Early‐Stage Detection of Hepatocellular Carcinoma" is currently up at

    Poništi
  8. 8. stu 2019.

    So this is happening.... See you in Boston!

    Poništi
  9. proslijedio/la je Tweet
    8. stu 2019.

    During , we’re sharing data demonstrating for detection of early stage . More about our efforts here:

    Poništi
  10. 7. stu 2019.

    Regulatory clarity is helpful, especially when building/using new tools. More discussion here of clinical interface vs. discovery tools.

    Poništi
  11. 5. stu 2019.

    And I am excited to be part of this team! See you in Boston?

    Poništi
  12. proslijedio/la je Tweet
    17. lis 2019.
    Poništi
  13. 17. lis 2019.

    Great thread overall and this comment stuck out. Public vs. Private company CEO = very different jobs

    Poništi
  14. 16. lis 2019.
    Poništi
  15. 12. lis 2019.

    Start of WSJ article on quantitative easing today but resonates for those of us who are or communicate with scientists, clinicians & regulators. “When I use a word,” Humpty Dumpty said, in rather a scorn­ful tone, “it means just what I choose it to mean—nei­ther more nor less.”

    Poništi
  16. 4. lis 2019.

    After listening to discuss drug shortages with I am interested in your thoughts on CivicaRx, health system + philanthropy led non profit to address generic drug shortages. Looks like their vancomycin already available.

    Poništi
  17. proslijedio/la je Tweet

    3/ DATA GAPS: We still struggle to capture disease status in the . Cancer staging and status are not the same - stable disease, progression, etc.

    Prikaži ovu nit
    Poništi
  18. 3. lis 2019.

    Looking to join a team where you can make a difference? Our Clinical and Regulatory Affairs team (includes me) is looking for a Senior Project Coordinator

    Poništi
  19. 2. lis 2019.

    Honored to introduce today when she receives the Wisconsin Biohealth Business Achievement Award

    Poništi
  20. proslijedio/la je Tweet

    Best article I have seen on vaping as a chaotic medical experiment. "We're conducting a big, uncontrolled and poorly documents set of chemistry experiments inside people's lungs"

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·